Methods for multi-ancestry and multi-trait fine-mapping and genetic risk prediction

多祖先、多性状精细定位和遗传风险预测方法

• 批准号: 10678066
• 负责人: Jordan Rossen
• 金额: $ 3.99万
• 依托单位: HARVARD SCHOOL OF PUBLIC HEALTH
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-25 至 2026-06-24
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10678066
• 关键词: Acceleration; Biology; Clinic; Collection; Data; Data Collection; Data Set; Development; Disease; Drug Targeting; Electronic Health Record; Equity; Etiology; European; European ancestry; Genetic; Genetic Risk; Goals; Individual; Intervention; Laplacian; Linkage Disequilibrium; Maps; Medical; Methodology; Methods; Modeling; Pattern; Performance; Phenotype; Population; Population Heterogeneity; Publishing; Research; Research Personnel; Risk; Scoring Method; Speed; Statistical Models; Sum; Time; Variant; base; biobank; causal variant; data privacy; disease-causing mutation; disorder risk; electronic health information; falls; genetic architecture; genetic epidemiology; genetic information; genetic variant; health disparity; health inequalities; health outcome disparity; high standard; improved; innovation; insight; interest; polygenic risk score; precision medicine; risk prediction; screening; statistics; trait; trend

Project Summary: Two fundamental goals in genetic epidemiology are the identification of genetic variants that cause disease (fine-mapping) and the development of polygenic risk scores (PRS) that predict individual- level disease risk using genetic information. As genetic datasets expand, these goals become increasingly realistic. However, most genetic datasets overrepresent European populations, limiting the generalizability of scientific findings, the discovery of causal variants, and the accuracy of PRS in non-European populations. If unaddressed, differences in PRS accuracy will widen ancestry-based health disparities. Most methods in genetic epidemiology consider one ancestry and disease at a time. This research proposes methods for causal variant identification and genetic risk prediction that share information across ancestries and diseases. The first aim is to develop a method for fine-mapping using data from multiple ancestry groups. Causal variant identification provides insight into disease etiology and helps researchers identify drug targets. The sum of single effects (SuSiE) model is a powerful approach for fine-mapping in a single population. Incorporating data from multiple populations can greatly improve fine-mapping due to ancestry-based differences in patterns of correlation between variants and the presence of variants with causal effects in some, but not all ancestries. In this aim, MultiSuSiE, a multi-population fine-mapping method motivated by SuSiE will be developed and applied. SuSiE provides substantial benefits in terms of speed, power, and interpretability compared to other fine-mapping methods. MultiSuSiE will bring the state-of-the-art in fine-mapping to the multi-ancestry context. The second aim is to develop and apply ssCTPR, a summary statistic based PRS method that leverages shared information across diseases. PRS show great promise for informing medical treatment decisions and disease screening interventions. A recent method, cross-trait penalized regression (CTPR), boosts prediction accuracy by leveraging shared genetic bases across diseases but requires difficult-to-obtain individual-level data. In this aim, ssCTPR, a multi-trait summary statistic-based method motivated by CTPR will be developed and applied. ssCTPR is innovative in its statistical approach: ssCTPR will jointly model variants and diseases, use penalized regression, and share information across traits using a Laplacian quadratic penalty that is effective in the multi-disease setting, but has not been investigated using summary statistics. The third aim is to develop a method that uses the methodological advances of aims 1 and 2 to improve PRS prediction in non-European populations. PRS prediction accuracy in non-European populations is much lower than in European populations. As PRS enter the clinic, populations with inequitable health outcomes will fail to benefit from the latest in precision medicine innovation. In this aim, MultiPolyPred, a method that models individual risk using multi-ancestry fine-mapping and a multi-disease PRS will be developed and applied. Our method will be the only non-European PRS method to leverage multi-ancestry fine-mapping.

项目概述：遗传流行病学的两个基本目标是遗传变异的鉴定